Global Valsartan (CAS 137862-53-4) Market Outlook 2016-2021

Published: Aug, 2016 | Pages: 106 | Publisher: Gen Consulting Company
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Valsartan (trade name Diovan) is an angiotensin II receptor antagonist (commonly called an ARB, or angiotensin receptor blocker), that is selective for the type I (AT1) angiotensin receptor. Valsartan is mainly used for treatment of high blood pressure, congestive heart failure, and to increase the chances of living longer after a heart attack.

This report provides detailed analysis of worldwide markets for Valsartan (CAS 137862-53-4) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Valsartan (CAS 137862-53-4) market and further lays out an analysis of the factors influencing the supply/demand for Valsartan (CAS 137862-53-4), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

GCC's report, Global Valsartan (CAS 137862-53-4) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Valsartan (CAS 137862-53-4) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Valsartan (CAS 137862-53-4) market are Novartis Pharma (Switzerland), Taj Pharmaceuticals (India), Divis Laboratories (India), Zhejiang Tianyu (China), Zhuhai Rundu (China), Zhejiang Kinglyuan (China), Shanghai Kony (China), Changzhou Siyao (China), Second Pharma (China), Zhejiang Huahai (China), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Valsartan (CAS 137862-53-4) industry has been provided.

 Table of Contents

Part 1. Scope of Report
1.1 Methodology
1.2 Geographic Scope
1.3 Years Considered

Part 2. Introduction
2.1 Definition
2.2 Current Scenario
2.2 Future Scenario

Part.3 Value Chain Analysis
3.1 Upstream
3.2 Downstream

Part 4. Manufacture
4.1 Manufacturing Process
4.2 Issues and Trends
4.3 Manufacturing Costs

Part 5. Worldwide Key Vendors
5.1 Company A
5.1.1 Business Overview
5.1.2 Products Offered
5.1.3 Business Performance
5.2 Company B
5.3 Company C
5.4 Company D
5.5 Company E
5.6 Company F
5.7 Company G
5.8 Company H
5.9 Company I
5.10 Company J

Part 6. Market Overview
6.1 Global Production Volume 2011-2016
6.2 Production Volume by Region 2011-2016
6.2.1 North America
6.2.2 EMEA
6.2.3 Asia-Pacific
6.2.4 ROW
6.3 Global Production Value 2011-2016
6.4 Production Value by Region
6.4.1 North America
6.4.2 EMEA
6.4.3 Asia-Pacific
6.4.4 ROW

Part 7. Consumption Pattern
7.1 Regional Consumption
7.1.1 North America
7.1.2 EMEA
7.1.3 Asia-Pacific
7.1.4 ROW
7.2 Global Consumption by Application

Part 8. Market Forecast
8.1 Market Size by Volume
8.1.1 North America
8.1.2 EMEA
8.1.3 Asia-Pacific
8.1.4 ROW
8.2 Market Size by Value
8.2.1 North America
8.2.2 EMEA
8.2.3 Asia-Pacific
8.2.4 ROW
8.3 Regional Consumption Forecast
8.3.1 North America
8.3.2 EMEA
8.3.3 Asia-Pacific
8.3.4 ROW
8.4 Consumption Forecast by Application

Part 9. Market Dynamics
9.1 Market Drivers
9.2 Market Constraints
9.3 Market Strategies

Part 10. Key Events
10.1 Mergers & Acquisitions
10.2 New Product Launches
10.3 Expansions
10.4 Other Developments

List of Tables and Figures


Figure Global Valsartan (CAS 137862-53-4) Production Volume (Unit) 2011-2016
Figure Global Valsartan (CAS 137862-53-4) Production Value (M USD) 2011-2016
Figure Top 10 Valsartan (CAS 137862-53-4) Vendors Production Volume Share 2015
Figure Top 10 Valsartan (CAS 137862-53-4) Vendors Production Value Share 2015
Figure Regional Valsartan (CAS 137862-53-4) Production (Unit) 2015
Figure Regional Valsartan (CAS 137862-53-4) Production Value (M USD) 2015
Table Raw Material Materials Suppliers
Figure Global Valsartan (CAS 137862-53-4) Consumption Pattern 2015
Figure Manufacturing Cost Structure
Figure Company A Valsartan (CAS 137862-53-4) Products
Table Company A Financial Performance 2011-2016
Figure Company A Market Share 2011-2016
Figure Company B Valsartan (CAS 137862-53-4) Products
Table Company B Financial Performance 2011-2016
Figure Company B Market Share 2011-2016
Figure Company C Valsartan (CAS 137862-53-4) Products
Table Company C Financial Performance 2011-2016
Figure Company C Market Share 2011-2016
Figure Company D Valsartan (CAS 137862-53-4) Products
Table Company D Financial Performance 2011-2016
Figure Company D Market Share 2011-2016
Figure Company E Valsartan (CAS 137862-53-4) Products
Table Company E Financial Performance 2011-2016
Figure Company E Market Share 2011-2016
Figure Company F Valsartan (CAS 137862-53-4) Products
Table Company F Financial Performance 2011-2016
Figure Company F Market Share 2011-2016
Figure Company G Valsartan (CAS 137862-53-4) Products
Table Company G Financial Performance 2011-2016
Figure Company G Market Share 2011-2016
Figure Company H Valsartan (CAS 137862-53-4) Products
Table Company H Financial Performance 2011-2016
Figure Company H Market Share 2011-2016
Figure Company I Valsartan (CAS 137862-53-4) Products
Table Company I Financial Performance 2011-2016
Figure Company I Market Share 2011-2016
Figure Company J Valsartan (CAS 137862-53-4) Products
Table Company J Financial Performance 2011-2016
Figure Company J Market Share 2011-2016
Table Global Key Valsartan (CAS 137862-53-4) Vendors Production (Unit) 2011-2016
Table Global Key Valsartan (CAS 137862-53-4) Vendors Production Share 2011-2016
Figure Global Valsartan (CAS 137862-53-4) Capacity & Production (Unit), Capacity Utilization 2011-2016
Figure Global Top 10 Valsartan (CAS 137862-53-4) Vendors Production (Unit) 2011-2016
Table Global Top 10 Valsartan (CAS 137862-53-4) Vendors Production (Unit) 2011
Table Global Top 10 Valsartan (CAS 137862-53-4) Vendors Production (Unit) 2012
Table Global Top 10 Valsartan (CAS 137862-53-4) Vendors Production (Unit) 2013
Table Global Top 10 Valsartan (CAS 137862-53-4) Vendors Production (Unit) 2014
Table Global Top 10 Valsartan (CAS 137862-53-4) Vendors Production (Unit) 2015
Table Global Top 10 Valsartan (CAS 137862-53-4) Vendors Production (Unit) 2016
Figure Valsartan (CAS 137862-53-4) Production Volume (Unit) 2011-2016
Table Global Production Volume (Unit) 2011-2016
Table Global Production Volume Share 2011-2016
Figure North America Valsartan (CAS 137862-53-4) Capacity & Production (Unit)
Figure North America Production Share Trend
Figure EMEA Valsartan (CAS 137862-53-4) Capacity & Production (Unit)
Figure EMEA Production Share Trend
Figure Asia-Pacific Valsartan (CAS 137862-53-4) Capacity & Production (Unit)
Figure Asia-Pacific Production Share Trend
Figure ROW Valsartan (CAS 137862-53-4) Capacity & Production (Unit)
Figure ROW Production Share Trend Change
Figure Global Valsartan (CAS 137862-53-4) Production Value (M USD), Growth Rate
Table Global Key Valsartan (CAS 137862-53-4) Vendors Production Value (M USD) 2011-2016
Table Global Key Valsartan (CAS 137862-53-4) Vendors Production Value Share 2011-2016
Figure Global Top 10 Valsartan (CAS 137862-53-4) Vendors Production Value (M USD) 2011-2016
Table Global Top 10 Valsartan (CAS 137862-53-4) Vendors Production Value (M USD) 2011
Table Global Top 10 Valsartan (CAS 137862-53-4) Vendors Production Value (M USD) 2012
Table Global Top 10 Valsartan (CAS 137862-53-4) Vendors Production Value (M USD) 2013
Table Global Top 10 Valsartan (CAS 137862-53-4) Vendors Production Value (M USD) 2014
Table Global Top 10 Valsartan (CAS 137862-53-4) Vendors Production Value (M USD) 2015
Table Global Top 10 Valsartan (CAS 137862-53-4) Vendors Production Value (M USD) 2016
Figure Valsartan (CAS 137862-53-4) Prices (USD/Ton) 2016
Figure Valsartan (CAS 137862-53-4) Gross Margin 2016
Figure Valsartan (CAS 137862-53-4) Production Value (M USD) By Region 2011-2016
Table Global Valsartan (CAS 137862-53-4) Production Value (M USD) 2011-2016
Table Global Valsartan (CAS 137862-53-4) Production Value Share 2011-2016
Figure North America Production Value (M USD), Growth Rate
Figure North America Valsartan (CAS 137862-53-4) Production Value Share Trend
Figure EMEA Production Value (M USD), Growth Rate
Figure EMEA Valsartan (CAS 137862-53-4) Production Value Share Trend
Figure Asia-Pacific Production Value (M USD), Growth Rate
Figure Asia-Pacific Valsartan (CAS 137862-53-4) Production Value Share Trend
Figure ROW Production Value (M USD), Growth Rate
Figure ROW Valsartan (CAS 137862-53-4) Production Value Share Trend
Figure Global Valsartan (CAS 137862-53-4) Consumption Volume (Unit) 2015
Table Regional Valsartan (CAS 137862-53-4) Consumption Volume (Unit) 2011-2016
Table Regional Valsartan (CAS 137862-53-4) Consumption Volume Share 2011-2016
Figure Valsartan (CAS 137862-53-4) Consumption in North America 2011-2016
Figure Valsartan (CAS 137862-53-4) Consumption in EMEA 2011-2016
Figure Valsartan (CAS 137862-53-4) Consumption in Asia-Pacific 2011-2016
Figure Valsartan (CAS 137862-53-4) Consumption in ROW 2011-2016
Figure Global Valsartan (CAS 137862-53-4) Consumption Volume (Unit) 2016
Table Global Valsartan (CAS 137862-53-4) Consumption Volume (Unit) 2011-2016
Table Global Valsartan (CAS 137862-53-4) Consumption Volume Share 2011-2016
Figure Global Valsartan (CAS 137862-53-4) Production (Unit) Forecast 2016-2021
Table Global Valsartan (CAS 137862-53-4) Production (Unit) 2016-2021
Table Global Valsartan (CAS 137862-53-4) Production Share 2016-2021
Figure North Valsartan (CAS 137862-53-4) Production (Unit) Forecast 2016-2021
Figure EMEA Valsartan (CAS 137862-53-4) Production (Unit) Forecast 2016-2021
Figure Asia-Pacific Valsartan (CAS 137862-53-4) Production (Unit) Forecast 2016-2021
Figure ROW Valsartan (CAS 137862-53-4) Production (Unit) Forecast 2016-2021
Figure Global Valsartan (CAS 137862-53-4) Revenue (M USD) Forecast 2016-2021
Table Global Valsartan (CAS 137862-53-4) Revenue (M USD) 2016-2021
Table Global Valsartan (CAS 137862-53-4) Revenue Share 2016-2021
Figure North America Valsartan (CAS 137862-53-4) Revenue (M USD) Forecast 2016-2021
Figure EMEA Valsartan (CAS 137862-53-4) Revenue (M USD) Forecast 2016-2021
Figure Asia-Pacific Valsartan (CAS 137862-53-4) Revenue (M USD) Forecast 2016-2021
Figure ROW Valsartan (CAS 137862-53-4) Revenue (M USD) Forecast 2016-2021
Figure Global Valsartan (CAS 137862-53-4) Consumption Volume (Unit) 2016-2021
Table Global Valsartan (CAS 137862-53-4) Consumption Volume (Unit) 2016-2021
Table Global Valsartan (CAS 137862-53-4) Consumption Volume Share 2016-2021
Figure North America Valsartan (CAS 137862-53-4) Consumption (Unit) Forecast
Figure EMEA Valsartan (CAS 137862-53-4) Consumption (Unit) Forecast
Figure Asia-Pacific Valsartan (CAS 137862-53-4) Consumption (Unit) Forecast
Figure ROW Valsartan (CAS 137862-53-4) Consumption (Unit) Forecast
Figure Global Valsartan (CAS 137862-53-4) Consumption Volume (Unit) 2021
Table Global Valsartan (CAS 137862-53-4) Consumption Volume (Unit) 2016-2021
Table Global Valsartan (CAS 137862-53-4) Consumption Volume Share 2016-2021
Table Key Strategies for Valsartan (CAS 137862-53-4) Multinational Corporations
Table Key Strategies for Valsartan (CAS 137862-53-4) Emerging-Market Players